AngioLab (XKRX:251280) General and Admin. Expense : ₩41.7 Mil (TTM As of Dec. 2023)

View and export this data going back to 2016. Start your Free Trial

What is AngioLab General and Admin. Expense?

General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. AngioLab's General and Admin. Expense for the six months ended in Dec. 2023 was ₩41.7 Mil. Its General and Admin. Expense for the trailing twelve months (TTM) ended in Dec. 2023 was ₩41.7 Mil.

AngioLab General and Admin. Expense Historical Data

The historical data trend for AngioLab's General and Admin. Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AngioLab General and Admin. Expense Chart

AngioLab Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

General and Admin. Expense

Get a 7-Day Free Trial

60.09

40.82

29.80

35.02

41.74

AngioLab Semi-Annual Data
	Dec17	Dec18	Dec19	Dec20	Dec21	Dec22	Dec23
General and Admin. Expense	Get a 7-Day Free Trial			60.09	40.82	29.80	35.02	41.74

AngioLab General and Admin. Expense Calculation

General and Admin. Expense is the aggregate total of general managing and administering expenses for the company.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. General and Admin. Expense for the trailing twelve months (TTM) ended in Dec. 2023 was ₩41.7 Mil.

AngioLab General and Admin. Expense Related Terms

Thank you for viewing the detailed overview of AngioLab's General and Admin. Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

AngioLab (XKRX:251280) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » AngioLab Inc (XKRX:251280) » Definitions » General and Admin. Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

65 Techno 3ro, Suite 159, Hanshin S Mecca, Yuseong-gu, Doejeon, CHN

Website

http://www.angiolab.co.kr

AngioLab Inc is a biotechnology company. It develops products based on angiogenesis inhibitors. It discovers, develops, and markets anti-angiogenic candidates to inhibit the abnormal growth of new blood vessel.

AngioLab (XKRX:251280) Headlines

No Headlines